Brian Bressler, MD, MS, FRCPC

St. Paul’s Hospital, Canada

Poster(s):

• P2198 - The Efficacy of Induction Treatment with Guselkumab in Patients with Moderately to Severely Active Ulcerative Colitis: Phase 3 QUASAR Induction Study Results at Week 12 by Prior Advanced Therapy History
  Monday, October 23, 2023

  10:30 AM – 4:15 PM PT

• P2199 - Guselkumab Improves Health-Related Quality of Life in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the QUASAR Phase 3 Induction Study
  Monday, October 23, 2023

  10:30 AM – 4:15 PM PT